Edgewise Therapeutics, Inc. (EWTX)

NASDAQ: EWTX · IEX Real-Time Price · USD

15.45

-0.20 (-1.28%)

At close: Apr 18, 2024, 4:00 PM

15.18

-0.27 (-1.75%)

After-hours: Apr 18, 2024, 4:07 PM EDT

Edgewise Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-100.16	-67.64	-42.81	-17.12	-9.71
Depreciation & Amortization	1.73	0.54	0.27	0.19	0.12
Share-Based Compensation	17.56	10.92	4.4	0.35	0.08
Other Operating Activities	-11.08	3.54	4.63	1.95	0.33
Operating Cash Flow	-91.95	-52.64	-33.51	-14.63	-9.17
Capital Expenditures	-5.75	-5.55	-0.67	-0.2	-0.18
Change in Investments	108.63	-65.03	-241.56	-24.18	0
Investing Cash Flow	102.89	-70.58	-242.23	-24.38	-0.18
Share Issuance / Repurchase	53.33	129.89	186.51	0.2	0.02
Other Financing Activities	-0.17	-0.25	-0.12	120.08	24.78
Financing Cash Flow	53.17	129.64	186.38	120.28	24.8
Net Cash Flow	64.1	6.43	-89.35	81.26	15.45
Free Cash Flow	-97.69	-58.18	-34.18	-14.84	-9.35
Free Cash Flow Per Share	-1.53	-1.09	-0.91	-20.08	-24.75

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).